CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 50,000 shares at an average $0.51 ($25,350)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 75,000 shares at an average $0.51 ($38,565)
- 4 Open-market buy Chief Executive Officer bought 17,231 shares at $0.52 ($8,960)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Executive or director change · Other events
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- 8-K Event Material agreement · Executive or director change
- 4 Open-market buy Director bought 25,000 shares at an average $0.52 ($13,044)
- 4 Open-market buy Director bought 963,637 shares at $0.55 ($530,000)
- 4 Open-market buy 10% owner bought 281,819 shares at $0.55 ($155,000)
Page 24 of 59 · 1,164 filings